Breathtec Biomedical Provides Corporate Overview
Company provides update of events and outlook for near term opportunity
Cognoa Begins Clinical Study to Support Increased Parent Engagement in Early Detection and Early Intervention of Developmental Delays
PALO ALTO, CA — (Marketwired) — 12/03/15 — , the healthcare company changing how parents evaluate and support their child–s development, today announces the start of a multi-site clinical study with leading developmental centers. The study will leverage the use of Cognoa–s innovative web and mobile tools to speed up the screening, assessment and care of children at risk for developmental delay. Findings could help large centers reduce barriers that delay intervention such as long wait time
XClinical’s EDC System MARVIN Convinces One of Europe’s Premier Pharma Companies
One of XClinical’s customers, the Munich-based CRO OSE Oncology Services Europe S.a.r.l., has just started a large clinical trial for one of Europe’s premier pharmaceutical companies.
XCLINICAL INVITED TO SPEAK AT TWO CDISC USER GROUP MEETINGS IN 2008
XClinical executives will be presenting at two important CDISC European User Group Meetings in January 2008.